open access

Vol 81, No 4 (2022)
Original article
Submitted: 2021-10-03
Accepted: 2021-10-21
Published online: 2021-10-28
Get Citation

Possible protective and curative effects of selenium nanoparticles on testosterone-induced benign prostatic hyperplasia rat model

W. A. Elfakharany1, M. M. Safwat1, A. S. Essawy23
·
Pubmed: 34730228
·
Folia Morphol 2022;81(4):942-955.
Affiliations
  1. Human Anatomy and Embryology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
  2. Human Anatomy and Embryology Department, Faculty of Medicine, Menoufia University, Menoufia, Egypt
  3. Anatomy Department, Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia

open access

Vol 81, No 4 (2022)
ORIGINAL ARTICLES
Submitted: 2021-10-03
Accepted: 2021-10-21
Published online: 2021-10-28

Abstract

Background: Men over the age of 40 are more likely to develop benign prostatic hyperplasia (BPH). BPH is characterised by proliferation of the prostatic epithelium and stroma. Selenium in the form of nanoparticles is an essential metalloid mineral and antioxidant. In this study, selenium nanoparticles (SeNPs) were tested for their potential protective and curative impacts on BPH in rats.
Materials and methods: Fifty male Sprague-Dawley rats were randomly divided into five groups: Group I (Control group); Group II (Orchiectomised group): bilateral orchiectomy was conducted on rats; Group III (BPH group): testosterone (TE) enanthate injection was used to induce BPH; Group IV (Protective group): rats were given SeNPs before subjecting rats to BPH; Group V (Curative group): rats were succumbed to BPH, followed by administration of SeNPs. Measurement of prostate specific antigen (PSA) and TE in serum was performed and prostates were weighed and prepared for histological, immunohistochemical and ultrastructural examination.
Results: In the BPH group, serum TE and PSA levels, as well as prostate weight, increased significantly and significant decreases were observed in the protective and curative groups. Reduced acinar lumen, expansion of stroma and epithelial hyperplasia were noticed in the BPH group, which were ameliorated significantly in both the protective and curative groups. There was an increase in proliferating cell nuclear antigen immunoreaction in the BPH group and a decrease in both the protective and curative groups. On transmission electron microscopy of BPH group, the nuclei appeared irregular with dilated endoplasmic reticulum, loss of cell boundaries and apical microvilli. The protective group showed more improvement than the curative group.
Conclusions: The effects of SeNPs on BPH induced by TE in rats, were both protective and curative, although the protective effects were more pronounced.

Abstract

Background: Men over the age of 40 are more likely to develop benign prostatic hyperplasia (BPH). BPH is characterised by proliferation of the prostatic epithelium and stroma. Selenium in the form of nanoparticles is an essential metalloid mineral and antioxidant. In this study, selenium nanoparticles (SeNPs) were tested for their potential protective and curative impacts on BPH in rats.
Materials and methods: Fifty male Sprague-Dawley rats were randomly divided into five groups: Group I (Control group); Group II (Orchiectomised group): bilateral orchiectomy was conducted on rats; Group III (BPH group): testosterone (TE) enanthate injection was used to induce BPH; Group IV (Protective group): rats were given SeNPs before subjecting rats to BPH; Group V (Curative group): rats were succumbed to BPH, followed by administration of SeNPs. Measurement of prostate specific antigen (PSA) and TE in serum was performed and prostates were weighed and prepared for histological, immunohistochemical and ultrastructural examination.
Results: In the BPH group, serum TE and PSA levels, as well as prostate weight, increased significantly and significant decreases were observed in the protective and curative groups. Reduced acinar lumen, expansion of stroma and epithelial hyperplasia were noticed in the BPH group, which were ameliorated significantly in both the protective and curative groups. There was an increase in proliferating cell nuclear antigen immunoreaction in the BPH group and a decrease in both the protective and curative groups. On transmission electron microscopy of BPH group, the nuclei appeared irregular with dilated endoplasmic reticulum, loss of cell boundaries and apical microvilli. The protective group showed more improvement than the curative group.
Conclusions: The effects of SeNPs on BPH induced by TE in rats, were both protective and curative, although the protective effects were more pronounced.

Get Citation

Keywords

selenium nanoparticles, testosterone, benign prostatic hyperplasia, rat

About this article
Title

Possible protective and curative effects of selenium nanoparticles on testosterone-induced benign prostatic hyperplasia rat model

Journal

Folia Morphologica

Issue

Vol 81, No 4 (2022)

Article type

Original article

Pages

942-955

Published online

2021-10-28

Page views

4532

Article views/downloads

972

DOI

10.5603/FM.a2021.0113

Pubmed

34730228

Bibliographic record

Folia Morphol 2022;81(4):942-955.

Keywords

selenium nanoparticles
testosterone
benign prostatic hyperplasia
rat

Authors

W. A. Elfakharany
M. M. Safwat
A. S. Essawy

References (63)
  1. Abdelnour SA, Alagawany M, Hashem NM, et al. Nanominerals: fabrication methods, benefits and hazards, and their applications in ruminants with special reference to selenium and zinc nanoparticles. Animals (Basel). 2021; 11(7).
  2. Al-Quraishy S, Dkhil MA, Abdel Moneim AE. Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats. Int J Nanomedicine. 2015; 10: 6741–6756.
  3. An Y, Zhao J. Functionalized selenium nanotherapeutics synergizes with zoledronic acid to suppress prostate cancer cell growth through induction of mitochondria-mediated apoptosis and cell cycle s phase arrest. Front Oncol. 2021; 11: 685784.
  4. Arvizo RR, Rana S, Miranda OR, et al. Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge. Nanomedicine. 2011; 7(5): 580–587.
  5. Austin DC, Strand DW, Love HL, et al. NF-κB and androgen receptor variant expression correlate with human BPH progression. Prostate. 2016; 76(5): 491–511.
  6. Aydin A, Arsova-Sarafinovska Z, Sayal A, et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia. Clin Biochem. 2006; 39(2): 176–179.
  7. Bancroft JD, Layton C. Connective and other mesenchymal tissues with their stains. In: Suvarna SK, Layton C, Bancroft JD (eds). Bancroft’s theory and practice of histological techniques. 8th ed. Churchill Livingstone, Elsevier, China 2018: 153–175.
  8. Bancroft JD, Layton C. Immunohistochemical and immunofluorescent techniques. In: Suvarna SK, Layton C, Bancroft JD (eds). Bancroft’s theory and practice of histological techniques. 8th ed. Churchill Livingstone, Elsevier, China 2018: 337–394.
  9. Bancroft JD, Layton C. The hematoxylins and eosin. In: Suvarna SK, Layton C, Bancroft JD (eds). Bancroft’s theory and practice of histological techniques. 8th ed. Churchill Livingstone, Elsevier,, China 2018: 126–138.
  10. Barbanente A, Nadar RA, Esposti LD, et al. Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells. J Mater Chem B. 2020; 8(14): 2792–2804.
  11. Bharali MKr, Chetry L. Aqueous methanolic bark extract of oroxylum indicum inhibited testosterone induced prostate hyperplasia in rat. Pharmacog J. 2014; 6(3): 79–85.
  12. Bian Q, Wang W, Wang N, et al. Quantification of arachidonic acid and its metabolites in rat tissues by UHPLC-MS/MS: application for the identification of potential biomarkers of benign prostatic hyperplasia. PLoS One. 2016; 11(11): e0166777.
  13. Briganti A, Capitanio U, Suardi N, et al. Benign Prostatic Hyperplasia and Its Aetiologies. Eur Urol Suppl. 2009; 8(13): 865–871.
  14. Bushman WA, Jerde TJ. The role of prostate inflammation and fibrosis in lower urinary tract symptoms. Am J Physiol Renal Physiol. 2016; 311(4): F817–F821.
  15. Choi HM, Jung Y, Park J, et al. Cinnamomi cortex (Cinnamomum verum) suppresses testosterone-induced benign prostatic hyperplasia by regulating 5α-reductase. Sci Rep. 2016; 6: 31906.
  16. Chughtai B, Forde JC, Thomas DD, et al. Benign prostatic hyperplasia. Nat Rev Dis Primers. 2016; 2: 16031.
  17. Cruz JA, Childs EE, Amatya N, et al. Interleukin-17 signaling triggers degradation of the constitutive NF-κB inhibitor ABIN-1. Immunohorizons. 2017; 1(7): 133–141.
  18. de Sousa VP, Crean J, de Almeida Borges VR, et al. Nanostructured systems containing babassu (Orbignya speciosa) oil as a potential alternative therapy for benign prostatic hyperplasia. Int J Nanomedicine. 2013; 8: 3129–3139.
  19. Descazeaud A, Weinbreck N, Robert G, et al. Transforming growth factor β-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation. BJU Int. 2011; 108(2 Pt 2): E23–E28.
  20. Dinarvand R, Sepehri N, Manoochehri S, et al. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine. 2011; 6: 877–895.
  21. Dkhil MA, Zrieq R, Al-Quraishy S, et al. Selenium nanoparticles attenuate oxidative stress and testicular damage in streptozotocin-induced diabetic rats. Molecules. 2016; 21(11).
  22. Donnell RF. Benign prostate hyperplasia: a review of the year's progress from bench to clinic. Curr Opin Urol. 2011; 21(1): 22–26.
  23. Durak l, Yılmaz E, Devrim E, et al. Consumption of aqueous garlic extract leads to significant improvement in patients with benign prostate hyperplasia and prostate cancer. Nutr Res. 2003; 23(2): 199–204.
  24. El-Deep MH, Ijiri D, Ebeid TA, et al. Effects of dietary nano-selenium supplementation on growth performance, antioxidative status, and immunity in broiler chickens under thermoneutral and high ambient temperature conditions. J Poult Sci. 2016; 53(4): 274–283.
  25. El-Ghazaly MA, Fadel N, Rashed E, et al. Anti-inflammatory effect of selenium nanoparticles on the inflammation induced in irradiated rats. Can J Physiol Pharmacol. 2017; 95(2): 101–110.
  26. El-Ramady H, Domokos-Szabolcsy É, Abdalla N, et al. Selenium and nano-selenium in agroecosystems. Environ Chem Lett. 2014; 12(4): 495–510.
  27. Gandaglia G, Briganti A, Gontero P, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int. 2013; 112(4): 432–441.
  28. Gonzales GF, Gasco M, Malheiros-Pereira A, et al. Antagonistic effect of Lepidium meyenii (red maca) on prostatic hyperplasia in adult mice. Andrologia. 2008; 40(3): 179–185.
  29. Jang H, Bae WJ, Yuk SM, et al. Seoritae extract reduces prostate weight and suppresses prostate cell proliferation in a rat model of benign prostate hyperplasia. Evid Based Complement Alternat Med. 2014; 2014: 475876.
  30. Kanter M, Aktas C, Erboga M. Curcumin attenuates testicular damage, apoptotic germ cell death, and oxidative stress in streptozotocin-induced diabetic rats. Mol Nutr Food Res. 2013; 57(9): 1578–1585.
  31. Kim KS, Yang HY, Chang SC, et al. Potential repositioning of GV1001 as a therapeutic agent for testosterone‑induced benign prostatic hyperplasia. Int J Mol Med. 2018; 42(4): 2260–2268.
  32. Krušlin B, Tomas D, Džombeta T, et al. Inflammation in prostatic hyperplasia and carcinoma-basic scientific approach. Front Oncol. 2017; 7: 77.
  33. La Vignera S, Condorelli RA, Russo GI, et al. Endocrine control of benign prostatic hyperplasia. Andrology. 2016; 4(3): 404–411.
  34. Lee G, Shin J, Choi H, et al. Cynanchum wilfordii ameliorates testosterone-induced benign prostatic hyperplasia by regulating 5α-reductase and androgen receptor activities in a rat model. Nutrients. 2017; 9(10).
  35. Lee MY. Effects of Platycodon grandiflorum methanolic extract on testosterone-induced benign prostatic hyperplasia in Wistar rats. Afr J Biotechnol. 2012; 11(77): 14186–14192.
  36. Li J, Tian Y, Guo S, et al. Testosterone-induced benign prostatic hyperplasia rat and dog as facile models to assess drugs targeting lower urinary tract symptoms. PLoS One. 2018; 13(1): e0191469.
  37. Lide DV. Handbook of Chemistry and Physics. 83rd ed. CRC Press, Clevland 2002.
  38. Lindshield BL, Ford NA, Canene-Adams K, et al. Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors. PLoS One. 2010; 5(4): e10423.
  39. Liu MC, Chen WH, Chiou CS, et al. Inhibition of chronic prostate inflammation by hyaluronic acid through an immortalized human prostate stromal cell line model. PLoS One. 2017; 12(5): e0178152.
  40. Malinen M, Niskanen EA, Kaikkonen MU, et al. Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome. Nucleic Acids Res. 2017; 45(2): 619–630.
  41. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978; 86(1): 271–278.
  42. Minutoli L, Altavilla D, Marini H, et al. Inhibitors of apoptosis proteins in experimental benign prostatic hyperplasia: effects of serenoa repens, selenium and lycopene. J Biomed Sci. 2014; 21: 19.
  43. Miroliaee AE, Esmaily H, Vaziri-Bami A, et al. Amelioration of experimental colitis by a novel nanoselenium-silymarin mixture. Toxicol Mech Methods. 2011; 21(3): 200–208.
  44. Nasr El-Din WA, Abdel Fattah IO. The potential curative and preventive effects of garlic on testosterone-induced benign prostatic hyperplasia in orchiectomized rats. Rom J Morphol Embryol. 2019; 60(1): 145–158.
  45. Park E, Lee MY, Jeon WY, et al. Inhibitory effect of yongdamsagan-tang water extract, a traditional herbal formula, on testosterone-induced benign prostatic hyperplasia in rats. Evid Based Complement Alternat Med. 2016; 2016: 1428923.
  46. Peng CC, Liu JH, Chang CH, et al. Action mechanism of ginkgo biloba leaf extract intervened by exercise therapy in treatment of benign prostate hyperplasia. Evid Based Complement Alternat Med. 2013; 2013: 408734.
  47. Robert G, Descazeaud A, Nicolaïew N, et al. Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis. Prostate. 2009; 69(16): 1774–1780.
  48. Sayed RH, Saad MA, El-Sahar AE. Dapoxetine attenuates testosterone-induced prostatic hyperplasia in rats by the regulation of inflammatory and apoptotic proteins. Toxicol Appl Pharmacol. 2016; 311: 52–60.
  49. Sayeed Q, Khatoon F, Bahmed F, et al. Effect of Testosterone and Estrogen Ratio-An indicator of Benign Prostatic Hyperplasia (BPH). Indian J Clin Anat Physiol. 2016; 3(2): 125.
  50. Sciarra A, Voria G, Mariotti G, et al. Histopathological aspects associated with the diagnosis of benign prostatic hyperplasia: clinical implications. Urol Int. 2002; 69(4): 253–262.
  51. Shukla S, Shankar E, Fu P, et al. Suppression of NF-κB and NF-κB-regulated gene expression by apigenin through IκBα and IKK pathway in TRAMP mice. PLoS One. 2015; 10(9): e0138710.
  52. Soliman HM, Abd El-Haleem MR, El Tarhouny SA. Histomorphometrical and electron microscopic study of adrenocorticocytes following surgically induced extrahepatic biliary obstruction in adult female albino rats. Folia Biol (Praha). 2015; 61(1): 14–25.
  53. Sonkusre P. Specificity of biogenic selenium nanoparticles for prostate cancer therapy with reduced risk of toxicity: an and study. Front Oncol. 2019; 9: 1541.
  54. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969; 27(3): 502–522.
  55. Vunta H, Davis F, Palempalli UD, et al. The anti-inflammatory effects of selenium are mediated through 15-deoxy-Delta12,14-prostaglandin J2 in macrophages. J Biol Chem. 2007; 282(25): 17964–17973.
  56. Vyas BA, Desai NY, Patel PK, et al. Effect of Boerhaavia diffusa in experimental prostatic hyperplasia in rats. Indian J Pharmacol. 2013; 45(3): 264–269.
  57. Wang CT, Wang YY, Liu WS, et al. Rhodobacter sphaeroides Extract Lycogen™ Attenuates Testosterone-Induced Benign Prostate Hyperplasia in Rats. Int J Mol Sci. 2018; 19(4).
  58. Wang EC, Wang AZ. Nanoparticles and their applications in cell and molecular biology. Integr Biol (Camb). 2014; 6(1): 9–26.
  59. Winner K, Polycarp O, Ifeoma I, et al. Effect of fractions of kolaviron on some indices of benign prostatic hyperplasia in rats: identification of the constituents of the bioactive fraction using GC-MS. RSC Advances. 2016; 6(97): 94352–94360.
  60. Woods AE, Stirling JW. Transmission electron microscopy. In: Suvarna SK, Layton C, Bancroft JD (eds). Bancroft’s theory and practice of histological techniques. 8th ed. Churchill Livingstone, Elsevier, China 2018: 434–475.
  61. Yang Y, Hu S, Liu J, et al. CD8+ T cells promote proliferation of benign prostatic hyperplasia epithelial cells under low androgen level via modulation of CCL5/STAT5/CCND1 signaling pathway. Sci Rep. 2017; 7: 42893.
  62. Zhang J, Wang X, Xu T. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with se-methylselenocysteine in mice. Toxicol Sci. 2008; 101(1): 22–31.
  63. Zhong X, Lin J, Zhou J, et al. Anti-proliferative effects of qianliening capsules on prostatic hyperplasia in vitro and in vivo. Mol Med Rep. 2015; 12(2): 1699–1708.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, Świętokrzyska 73, 80–180 Gdańsk, Poland

tel.: +48 58 320 94 94, faks: +48 58 320 94 60, e-mail: viamedica@viamedica.pl